David Fenton
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Epidemiology
- Cancer Research
- Co-authors
- Frances A. ShepherdMauro ZukinLesley SeymourFrancis LabergeCharles ButtsJonathan NobleCarolyn J. Peddle‐McIntyreQuincy S. Chu
- Topics
- Lung Cancer Treatments and Mutations (10 papers)Cancer Immunotherapy and Biomarkers (4 papers)Lung Cancer Research Studies (4 papers)
- Partner nations
- CanadaUnited KingdomUnited States
In The Last Decade
David Fenton
36 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 93
- Oncology 750
- Pulmonary and Respiratory Medicine 678
- Molecular Biology 253
- Epidemiology 161
- Cancer Research 96
Countries citing papers authored by David Fenton
This map shows the geographic impact of David Fenton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Fenton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Fenton more than expected).
Fields of papers citing papers by David Fenton
This network shows the impact of papers produced by David Fenton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Fenton. The network helps show where David Fenton may publish in the future.
Co-authorship network of co-authors of David Fenton
This figure shows the co-authorship network connecting the top 25 collaborators of David Fenton. A scholar is included among the top collaborators of David Fenton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Fenton. David Fenton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 34 | |
| 4 | 21 | |
| 5 | 6 | |
| 6 | 36 | |
| 7 | 1 | |
| 8 | 80 | |
| 9 | 30 | |
| 10 | 79 | |
| 11 | 54 | |
| 12 | 12 | |
| 13 | 60 | |
| 14 | 67 | |
| 15 | 2 | |
| 16 | 10 | |
| 17 | 52 | |
| 18 | 186 | |
| 19 | 25 | |
| 20 | 11 |
About David Fenton
David Fenton is a scholar working on Obstetrics and Gynecology, Oncology and Pulmonary and Respiratory Medicine, having authored 38 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Lung Cancer Research Studies (4 papers). The work is most often cited by research in Oncology (750 citations), Pulmonary and Respiratory Medicine (678 citations) and Obstetrics and Gynecology (56 citations). David Fenton has collaborated with scholars based in Canada, United Kingdom and United States. Frequent co-authors include Frances A. Shepherd, Mauro Zukin, Lesley Seymour, Francis Laberge, Charles Butts, Jonathan Noble, Carolyn J. Peddle‐McIntyre, Quincy S. Chu, Michael Smylie and Kerry S. Courneya. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.